Board appointment at Light Sciences Oncology
This article was originally published in Scrip
Executive Summary
Light Sciences Oncology (US) has elected Dr Frank Young to a newly created seat on its board of directors. He held positions in clinical practice, academia and government, including Commissioner of the FDA from 1984 to 1989. Dr Young is presently a partner at Essex Woodlands Health Ventures, an investor in Light Sciences Oncology.